| abstract |
Described herein are anti-SIRPα antibodies, polynucleotides encoding anti-SIRPα antibodies, host cells containing such polynucleotides, methods of making and using such anti-SIRPα antibodies or polynucleotides, pharmaceutical compositions containing such anti-SIRPα antibodies or polynucleotides, as well as mixtures or bispecific antibodies comprising such anti-SIRPα antibodies or polynucleotides encoding such mixtures or bispecific antibodies. |